{"disease":{"id":"acquired-hemophilia","name":"acquired hemophilia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03384277","title":"Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT02610127","title":"Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A","phase":"","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT03199794","title":"Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT01178294","title":"Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT06461533","title":"A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A","phase":"","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05849740","title":"An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT03700229","title":"Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":22,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06550882","title":"A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea","phase":"","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04580407","title":"Study of TAK-672 in Participants With Acquired Hemophilia A","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT01968655","title":"Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}